Sarah Miller, a 43-year-old female with a history of type 2 diabetes mellitus, essential hypertension, rheumatoid arthritis, and metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), presented with a recent episode of acute jaundice. She was previously on methotrexate 7.5 mg weekly, later reduced to 5 mg weekly, for rheumatoid arthritis, but it was stopped due to severe hepatocellular drug-induced liver injury (DILI) with cholestasis, evidenced by an ALT of 490 U/L and bilirubin of 110 Î¼mol/L. She is allergic to methotrexate, resulting in severe DILI. Her medications include metformin, ramipril, ibuprofen (PRN), simethicone (PRN), folic acid, N-acetylcysteine (NAC IV), and ursodeoxycholic acid (UDCA). What is the daily diagnosis according to EASL guideline for Sarah Miller?
